Subcutaneous apomorphine for parkinsonian patients with psychiatric side effects on oral treatment.
AUTOR(ES)
Ray-Chaudhuri, K
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=488501Documentos Relacionados
- Subcutaneous apomorphine in the treatment of Parkinson's disease.
- The apomorphine test in parkinsonian syndromes.
- Apomorphine in treatment of Parkinson's disease: comparison between subcutaneous and sublingual routes.
- Subcutaneous apomorphine in Parkinson's disease.
- Methylphenidate Abuse and Psychiatric Side Effects